Vaccine arrives at UW Health
UW Health received its first doses of the Pfizer COVID-19 vaccine the morning of Monday, Dec. 14....
UW Health received its first doses of the Pfizer COVID-19 vaccine the morning of Monday, Dec. 14....
Selected from more than 400 innovation disclosures, two University of Wisconsin-Madison teams working at the frontiers of cancer immunotherapy and bioengineering have taken top honors from WARF....
A team of researchers led by University of Wisconsin–Madison professor David Gamm is developing a transplantable retinal patch intended to help restore vision to military personnel blinded in the line of duty and to treat individuals with degenerative eye diseases such as macular degeneration....
Chancellor Rebecca Blank Doesn't Expect Campus Community To Have Access To Vaccines Until Late Spring Or Summer....
The lab of Kris Saha at the University of Wisconsin–Madison has developed an innovative combination of gene-editing tools and computational simulations that can be used to develop new strategies for editing genes associated with genetic disorders....
The Center for Technology Commercialization (CTC) is offering a matching grant of up to $100,000 to provide additional assistance to companies in the process of completing a project in the federal Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) programs....
2020 kept us busy at Wisconsin Inno, as we've worked to keep our readers up to speed with everything happening across the state's tech and startup scene. To recap the year that was, we wanted to take a look back at some of the biggest...
In this Badger Talks video, Tim Bertram, a University of Wisconsin–Madison professor of chemistry and an expert on air quality, discusses what we can do to minimize risk indoors....
Take a look at a Flipbook presentation of stunning ingenuity that went into the Exact Sciences / Innovation One building at University Research Park - created by J.H. Findorff....
Exact Sciences Corp. (NASDAQ: EXAS) today announced that data from the Rx for Positive Node, Endocrine Responsive Breast Cancer, or RxPONDER, trial successfully defined the benefit of chemotherapy in early-stage, node-positive breast cancer patients with Oncotype DX Breast Recurrence Score® results of 0 to 25....
Three University of Wisconsin–Madison professors — Charles Mistretta, Denise Ney and Ann Palmenberg — have been named fellows of the National Academy of Inventors. NAI fellowship honors academic inventors who have “demonstrated a spirit of innovation in creating or facilitating outstanding inventions that have made...
Discovery to Product (D2P) is pleased to share a recently completed report that presents some of our most impactful contributions to the campus innovation and entrepreneurship community....